Abstract:Background: Malignant tumors, mainly solid tumors, are a significant obstacle to the improvement of life expectancy at present. Epithelial cell adhesion molecule (EpCAM), a cancer stem cell biomarker, showed widespread expression in most normal epithelial cells and most cancers. Although the clinical significance of EpCAM in various malignant solid tumors has been studied extensively, the latent relationships between EpCAM and pathological and clinical characteristics in solid tumors and differences in the roles of EpCAM among tumors have not been clearly determined. The destination point of this study was to analyze the value of EpCAM in solid tumors in clinicopathological and prognostic dimension using a meta-analysis approach. Method and materials: A comprehensive and systematic search of the researches published up to March 7th, 2022, in PubMed, EMBASE, Web of Science, Cochrane library and PMC databases was performed. The relationships between EpCAM overexpression, clinicopathological characteristics, and survival outcomes were analyzed. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) and odds ratios (ORs) were estimated as indicators of the degree of correlation. This research was registered on PROSPERO (International prospective register of systematic reviews), ID: CRD42022315070. Results: In total, 57 articles and 14184 cases were included in this study. High EpCAM expression had a significant coherence with a poorer overall survival (OS) (HR: 1.30, 95% CI: 1.08–1.58, P < 0.01) and a worse disease-free survival (DFS) (HR: 1.58, 95% CI: 1.28–1.95, P < 0.01), especially of gastrointestinal tumors' OS (HR: 1.50, 95% CI: 1.15–1.95, P < 0.01), and DFS (HR: 1.84, 95% CI: 1.52–2.33, P < 0.01). The DFS of head and neck tumors (HR: 2.33, 95% CI: 1.51–3.61, P < 0.01) was also associated with the overexpression of EpCAM. There were no positive relationships between the overexpression of EpCAM and sex (RR: 1.03, 95% CI: 0.99–1.07, P = 0.141), T classification (RR: 0.93, 95% CI: 0.82–1.06, P = 0.293), lymph node metastasis (RR: 0.85, 95% CI: 0.54–1.32, P = 0.461), distant metastasis (RR: 0.97, 95% CI: 0.84–1.10, P = 0.606), vascular infiltration (RR: 1.05, 95% CI: 0.85–1.29, P = 0.611), and TNM stage (RR: 0.93, 95% CI: 0.83–1.04, P = 0.187). However, the overexpression of EpCAM exhibited a significant association with the histological grades (RR: 0.88, 95% CI: 0.80–0.97, P < 0.01). Conclusion: Based on pooled HRs, the positive expression of EpCAM was totally correlated to a worse OS and DFS in solid tumors. The expression of EpCAM was related to a worse OS in gastrointestinal tumors and a worse DFS in gastrointestinal tumors and head and neck tumors. Moreover, EpCAM expression was correlated with the histological grade. The results presented pointed out that EpCAM could serve as a prognostic biomarker for gastrointestinal and head and neck tumors. Systematic review registration: https://www.crd.york.ac.uk/prospero, identifier CRD42022315070.

EpCam and Wnt / β-catenin pathway expression in colon cancer

Expression and Clinical Significance of EpCAM and Β-Catenin Pathway in Colon Cancer

Expression of EpCAM and Wnt/ Β-Catenin in Human Colon Cancer.

Expression of Epithelial Cell Adhesion Molecule and Its Correlation with Β-Catenin and Its Clinical Prognostic Significance in Colorectal Cancer

Relationship Between Epithelial Cell Adhesion Molecule and Wingless/integrated-Β-catenin Signaling in Colon Cancer and the Effect of XAV939 on the Expression of Related Markers

Expression Pattern of Epithelial Cell Adhesion Molecule on Normal and Malignant Colon Tissues

Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis

Expression and clinical significance of β-catenin in breast cancer tissue

Clinical significance and prognostic value of β-catenin expression in colonic adenocarcinoma

Immunocyte Profiling Using Single-Cell Mass Cytometry Reveals EpCAM+ CD4+ T Cells Abnormal in Colon Cancer

Expression of β-catenin, cyclin D1 and c-myc in colorectal carcinoma

Extracellular Domain of EpCAM Enhances Tumor Progression Through EGFR Signaling in Colon Cancer Cells.

EpCAM associates with integrin and regulates cell adhesion in cancer cells

Study on expressions and clinical significance of β-catenin/c-myc by immunohistochemicalstaining to tissue microarrav in human colon cancer

Association of Wnt1/β-catenin with the Clinical Pathology and Prognosis of Esophageal Squamous Cell Carcinoma

Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis

[Expression of Beta-Catenin in Human Colorectal Adenoma and Carcinoma].

Expression of E-cadherin/catenin Complex in Breast Cancer

Expression of Β-Catenin, E-cadherin and Ki67 in Chemically Induced Mice Colorectal Cancer and Its Significance

Intracellular domain of epithelial cell adhesion molecule induces Wnt receptor transcription to promote colorectal cancer progression

Expression of NKD1 and Β-Catenin and Their Clinical Significance in Colorectal Carcinoma